A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients

Clinical trial NCT03629080 · COMPLETED

Trial details

NCT number: NCT03629080
Sponsor: Hookipa Biotech GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus (CMV) Infection Kidney Transplantation

Start date: 2018-12-12
Primary completion: 2022-06-22
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.